The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces it Has Been Awarded a Phase I STTR Grant Entitled "Soft LXR Agonists for Idiopathic Pulmonary Fibrosis"

 

Doylestown, PA. July 17, 2020 - FCCDC is pleased to announce it has been awarded a Phase I STTR research grant from the NIH with Prof. Ross Summer of Thomas Jefferson University as Principal Investigator, entitled "Soft LXR Agonists for Idiopathic Pulmonary Fibrosis."